Showing results (271-280 of 530) with videos related to
Sort By:
Pageof 53
Annals of Internal Medicine|September 23, 2018
Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled TrialDaniel H Solomon, Robert J Glynn, Jean G MacFadyen, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 10, 2008
Interstate variation in the burden of fragility fracturesAlison B King, Anna N A Tosteson, John B Wong, et al.Arthritis Care & Research|August 15, 2017
Patterns of Systemic Treatment for Psoriatic Arthritis in the US: 2004-2015Moa P Lee, Joyce Lii, Yinzhu Jin, et al.The Journal of Rheumatology|September 3, 2016
Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid ArthritisJaeJin An, Evo Alemao, Kristi Reynolds, et al.Plos One|February 14, 2018
Assessment of coronary vascular function with cardiac PET in relation to serum uric acidSeoyoung C Kim, Nishant R Shah, James R Rogers, et al.Rheumatology (Oxford, England)|April 25, 2018
The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION TrialDaniel H Solomon, Peter Libby, Neville D Yeomans, et al.Arthritis Research & Therapy|August 23, 2008
Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary studyGladys Ting, Sebastian Schneeweiss, Richard Scranton, et al.Arthritis and Rheumatism|August 1, 2008
Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groupsDaniel H Solomon, Robert J Glynn, Kenneth J Rothman, et al.Medical Care|April 30, 2003
Trends in knee magnetic resonance imagingDaniel H Solomon, Jeffrey N Katz, John A Carrino, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 13, 2016
Impact of the U.S. Food and Drug Administration's Safety-Related Announcements on the Use of Bisphosphonates After Hip FractureSeoyoung C Kim, Dae Hyun Kim, Helen Mogun, et al.Pageof 53